These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12421739)

  • 21. Statins: much more than just a lipid-lowering therapy.
    Raja SG; Dreyfus GD
    Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 23. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
    Pauriah M; Struthers AD; Lang CC
    Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
    [No Abstract]   [Full Text] [Related]  

  • 26. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 27. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.
    Lee JH; Lee DS; Kim EK; Choe KH; Oh YM; Shim TS; Kim SE; Lee YS; Lee SD
    Am J Respir Crit Care Med; 2005 Oct; 172(8):987-93. PubMed ID: 16002570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.
    Kostakou P; Kolovou G; Anagnostopoulou K; Theodoridis T; Galea V; Mihas C; Christopoulou-Cokkinou V; Cokkinos DV
    Arch Cardiovasc Dis; 2010 Jan; 103(1):26-32. PubMed ID: 20142117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niacin compared with ezetimibe.
    Lindsay AC; Halcox JP
    N Engl J Med; 2010 Mar; 362(11):1046; author reply 1048. PubMed ID: 20237352
    [No Abstract]   [Full Text] [Related]  

  • 31. Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.
    Prescrire Int; 2011 Apr; 20(115):94. PubMed ID: 21648210
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients: why is someone still using the phase I diet for patients at risk for atherosclerosis?
    Banks T
    Am J Cardiol; 1999 Mar; 83(5):818. PubMed ID: 10080453
    [No Abstract]   [Full Text] [Related]  

  • 33. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is it over for ezetimibe?
    Robinson JG; Davidson M
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
    Pokrovskiĭ AV; Goloviuk AL
    Angiol Sosud Khir; 2010; 16(2):7-11. PubMed ID: 21032867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
    Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
    Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.